Expansion of Manglam Industrial Park Plant: Boosting Pynomax-TX & Tacrovin Production

Galcare Pharmaceuticals announces the expansion of its GMP-certified manufacturing unit at Manglam Industrial Park, Jaipur. The expanded automated facility will double batch output for flagship dermatological formulations including Pynomax-TX cream and Tacrovin ointment.

Established in 2008 in Jaipur, Rajasthan, Galcare Pharmaceuticals has grown from a visionary dermatology initiative into a premier prescription-oriented healthcare organization. Governed by Founder Devkant Bhardwaj’s core corporate dictum—"Excellence through People and Innovation"—the company maintains absolute commitment to scientific precision, regulatory DCGI compliance, and bioequivalent Active Pharmaceutical Ingredient (API) quality.

Through continuous investments in our WHO-GMP certified manufacturing facilities at Manglam Industrial Park, Jaipur, Galcare ensures that every topical cream, gel, ointment, and solid oral dosage form meets global safety and stability standards. Today, over 30,000 dermatologists, medical specialists, and healthcare practitioners across 26 Indian states trust Galcare formulations to treat dermatological conditions ranging from melasma, vitiligo, and acne care to severe inflammatory skin disorders.

Furthermore, Galcare’s third-party contract manufacturing wing offers comprehensive formulation development, analytical testing, CTD documentation, and customized primary packaging for domestic and international brand partners. With a dedicated team of over 500 associates and a strong focus on internal promotion and employee growth, Galcare continues to shape the future of clinical skincare therapeutics.